CDP Site, Perth, Australia, Source: Hazer Group
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Hazer Group (ASX:HZR) shares surge after the company achieved first hydrogen and graphite production at its commercial demonstration plant in WA
  • HZR CEO and MD Glenn Corrie hailed the achievement as a significant milestone for the leading clean-tech developer
  • Throughout the first half of CY2024, Hazer plans to progressively scale up its operations, ensuring the safe execution of the performance testing program
  • HZR shares are up 15 per cent, trading at 69 cents at 12:25 pm AEDT

Hazer Group (ASX:HZR) shares have lifted about 15 per cent after the company achieved first hydrogen and graphite production at its commercial demonstration plant in Western Australia.

Hazer CEO and Managing Director Glenn Corrie hailed the achievement as a significant milestone for the leading clean-tech developer.

“This is a landmark achievement for Hazer, as we realise the successful start-up of our CDP and the production of low-cost, low-emissions hydrogen and graphitic carbon utilising our world-first pyrolysis technology,” he said.

“As the team strive towards extended continuous operation of the plant in 2024 we are excited to build on this momentum for the next scale-up of the technology with our global partners in key markets, including North America, Europe and Asia.”

Hazer plans to progressively scale up its operations throughout the first half of CY2024 to ensure the safe execution of the performance testing program.

The testing will focus on showcasing sustained operation at a commercial scale, contributing to Hazer’s global commercial project portfolio.

HZR shares were up 15 per cent, trading at 69 cents at 12:25 pm AEDT.

hzr by the numbers
More From The Market Online
The Market Online Video

The ASX Today: US Iran strikes kill hopes; ASX Ltd’s CHESS bungle rolls on & CommSec eyes SpaceX

Greetings and welcome to HotCopper’s the ASX Today for Tuesday of Week 22. I’m Jonathon Davidson, and I might have made a mistake in yesterday’s afternoo…
The Market Online Video

Specialist healthcare investors back Syntara ahead of milestone rich period

Syntara (ASX:SNT) has recently completed an $8m Placement of new shares to new and existing investors, and in conjunction, announced a Share
The Market Online Video

AFT Pharma delivers record FY26 as global growth accelerates

Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to talk about

Noxopharm leaps on confirmation of cancer-fighting potential with new Sofra data

Noxopharm has obtained new data showing how the Sofra technology platform will be leveraged to fight…